4
4D Lifetec
Biotechnology company promoting and developing screening and test systems for molecular diagnostics
About 4D Lifetec
4D Lifetec AG is a Swiss startup specializing in the development of innovative liquid biopsy assays for the early detection of cancer. The company operates in the healthcare diagnostics market, offering a non-genomic, multi-cancer liquid biopsy assay that is both ultra-precise and cost-effective. This assay is designed for personalized diagnostics, therapy monitoring, and preventive screening, making it complementary to existing biomarkers and empowering predictive AI tools.
4D Lifetec serves a diverse range of clients, including healthcare providers, diagnostic labs, and research institutions. The business model is centered around the sale of its proprietary liquid biopsy assays and related diagnostic services. Revenue is generated through direct sales, partnerships, and potentially through licensing agreements.
The company aims to create a breakthrough in early cancer diagnostics, providing a standardized and reliable method for early detection, which can significantly improve patient outcomes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Cham, Switzerland
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 87.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Techbio, Hard Tech, Techbio Drug Discovery, Digital Pharma
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Oct 2023 | $21M | $107M | Xlife Sciences | ↗ |
| SERIES B✓Equity / VC | Jul 2022 | $1.7M | $7M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for 4D Lifetec is 320 monthly website visits, up 166.7% over the last three months. 4D Lifetec's team grew 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Xlife Sciences
Other known investors1 additional known investor
VentureLab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about 4D Lifetec on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See 4D Lifetec’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.